Page last updated: 2024-10-17

dihydrolipoic acid and Pulmonary Fibrosis

dihydrolipoic acid has been researched along with Pulmonary Fibrosis in 1 studies

dihydrolipoic acid: RN given refers to parent cpd without isomeric designation
dihydrolipoic acid : A thio-fatty acid that is reduced form of lipoic acid. A potent antioxidant shown to directly destroy superoxide, hydroperoxy and hydroxyl radicals; also has neuroprotective and anti-tumour effects.
dihydrolipoate : The conjugate base of dihydrolipoic acid.

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantin, AM1
Martel, M1
Drouin, G1
Paquette, B1

Other Studies

1 other study available for dihydrolipoic acid and Pulmonary Fibrosis

ArticleYear
Inhibition of gelatinase B (matrix metalloproteinase-9) by dihydrolipoic acid.
    Canadian journal of physiology and pharmacology, 2005, Volume: 83, Issue:3

    Topics: Animals; Bronchoalveolar Lavage Fluid; Enzyme Inhibitors; Enzyme Precursors; Gelatinases; Humans; Ma

2005